BD

Felix Biotechnology to Collaborate with AnimalBiome on a Novel Solution for Pet Diarrhea

Retrieved on: 
Friday, January 14, 2022

The company has several on-going partnerships to develop phage-based solutions with personal care and cosmetic companies, and this deal expands their footprint into animal health.

Key Points: 
  • The company has several on-going partnerships to develop phage-based solutions with personal care and cosmetic companies, and this deal expands their footprint into animal health.
  • "We are committed to finding a better solution for this common affliction plaguing pets and distressing their owners," says Dr. Natalie Ma, Felix Cofounder and Head of BD at Felix.
  • AnimalBiome markets and sells a spectrum of products addressing digestive, skin, and oral health, from testing to targeted microbiome supplements to restore and maintain pet health.
  • Felix Biotechnology is focused on discovering, developing and deploying customizable antimicrobials targeting urgent microbial threats.

Outbrain Partners with Vivo to Provide Recommendations Across Browser Newsfeeds

Retrieved on: 
Wednesday, January 12, 2022

The easy integration of OB News into our platform allowed us to already see a marked improvement in our user engagement and monetization strategy, says Bob Xu, BD Director of Vivo.

Key Points: 
  • The easy integration of OB News into our platform allowed us to already see a marked improvement in our user engagement and monetization strategy, says Bob Xu, BD Director of Vivo.
  • We continue to work with top-tier OEMs to be the premier business partner in the industry, says Stephanie Himoff, VP of Publishers at Outbrain.
  • Our technology enables 10 billion daily recommendations to consumers across more than 7,000 online properties and connects advertisers to these audiences to grow their business.
  • vivo is a technology company that creates great products based on a design-driven value, with smart devices and intelligent services as its core.

IRME Letter to Shareholders

Retrieved on: 
Tuesday, January 11, 2022

New York, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK: IRME).

Key Points: 
  • New York, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK: IRME).
  • After months of behind-the-scenes efforts, Im excited to share with you what were workingand why Im looking forward to 2022 as a transformative period for our team and our shareholders.
  • Currently, PI can best be treated only after appearing on the patients skin: a sore or wound that requires considerable care.
  • Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties.

BD Named One of America's Most Just Companies in Annual JUST 100 Ranking

Retrieved on: 
Tuesday, January 11, 2022

Beingfeatured in the JUST 100 ranking recognizes the progress we are making across all of these areas."

Key Points: 
  • Beingfeatured in the JUST 100 ranking recognizes the progress we are making across all of these areas."
  • "The companies featured in the 2022 JUST 100 are demonstrating that purpose and profits can go hand in hand by delivering value to all stakeholders, including shareholders."
  • For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .
  • This selection of companies draws from the Russell 1000 Index, which represents over 90% of the U.S. stock market value.

Legion Capital Announces Securities Offering Sellout and Expansion to $75 Million

Retrieved on: 
Tuesday, January 11, 2022

The offering was re-qualified by the Securities and Exchange Commission (SEC) on Friday, January 7, 2022.

Key Points: 
  • The offering was re-qualified by the Securities and Exchange Commission (SEC) on Friday, January 7, 2022.
  • Added Plucinak, Continuing to expand our capital base is a critical component of meeting the growth plans and opportunities we have at Legion.
  • The securities are offered on a best-efforts basis on behalf of Legion Capital Corporation by Sequence Financial Specialists, LLC, as managing broker dealer, a member of FINRA and SIPC.
  • Legion Capital (OTCQB: LGCP) is a fintech enabled, publicly traded specialized business lender providing growth capital to small and medium sized companies.

AUM Biosciences Identifies Asymchem as the CDMO Partner of Choice for their Novel TRK inhibitor

Retrieved on: 
Tuesday, January 11, 2022

Under the terms of the agreement, AUM and Asymchem agree to collaborate on the process development, and the clinical and commercial production, of AUM 601, which is a highly selective oral small molecule inhibitor of the tropomyosin receptor kinase (TRK) for treating rare cancers.

Key Points: 
  • Under the terms of the agreement, AUM and Asymchem agree to collaborate on the process development, and the clinical and commercial production, of AUM 601, which is a highly selective oral small molecule inhibitor of the tropomyosin receptor kinase (TRK) for treating rare cancers.
  • "We are excited to partner with Asymchem in advancing our novel TRK inhibitor and believe the partnership will better allow us to reach our goal of transforming cancer care in the Asian landscape, and address unmet medical needs in the oncology space."
  • Founded in 1999, Asymchem is a leading global integrated Contract Development and Manufacturing Organization (CDMO) providing innovative drug R&D and manufacturing.
  • AUM Biosciences is a global clinical stage biotech company, focused on discovering and developing novel targeted oncology therapies, particularly for cancers with a clear genetic marker.

BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices

Retrieved on: 
Tuesday, January 11, 2022

FRANKLIN LAKES, N.J., Jan. 11, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration with Pfizer Inc. and global charitable foundation Wellcome to better understand the role of diagnostics in advancing antimicrobial stewardship practices around the world.

Key Points: 
  • FRANKLIN LAKES, N.J., Jan. 11, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration with Pfizer Inc. and global charitable foundation Wellcome to better understand the role of diagnostics in advancing antimicrobial stewardship practices around the world.
  • "Research shows us that significant barriers must be overcome to make health care workers aware of the importance and positive impact of diagnostics on AMR."
  • i
    AMR occurs when bacteria, viruses, fungi or parasites change over time and no longer respond to medicines.
  • We support discovery research into life, health and wellbeing, and we're taking on three worldwide health challenges:mental health, infectious disease and climate.

Callie Cox Joins Social investment network eToro as Investment Analyst

Retrieved on: 
Friday, January 7, 2022

She will be based in Charlotte, N.C.

Key Points: 
  • She will be based in Charlotte, N.C.
    Lule Demmissie, eToro's US CEO said: "We're thrilled to welcome Callie Cox to the eToro team.
  • Callie joins eToro from Ally Invest where she held the role of Senior Investment Strategist.
  • Callie Cox, eToro's Investment Analystadded: "I'm extremely excited to be joining the growing team at eToro.
  • As a social investment network, eToro has a very unique, community-oriented offering and I'm excited to bring my experience to the table to help make investing more accessible to everyone."

BD Introduces Smart Connected Robotics to Automate Microbial Identification

Retrieved on: 
Friday, January 7, 2022

With the BD Kiestra IdentifA, the lab technician uses BD Synapsys informatics to select discrete bacterial colonies from a digital plate image.

Key Points: 
  • With the BD Kiestra IdentifA, the lab technician uses BD Synapsys informatics to select discrete bacterial colonies from a digital plate image.
  • Sophisticated robotics then physically pick those selected organisms and prepare the sample for specific identification testing.
  • "BD continues to invest in automation and innovation for the microbiology laboratory to enable smart, connected, end-to-end workflows designed to accelerate insights and efficiency," said Brooke Story, president of Integrated Diagnostic Solutions for BD.
  • For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .

BD Announces Change to Virtual 2022 Annual Meeting of Shareholders

Retrieved on: 
Thursday, January 6, 2022

Shareholders will not be able to attend the 2022 Annual Meeting in person; however, shareholders of record at the close of business on December 6, 2021 will be able to attend and participate in the virtual 2022 Annual Meeting, vote their shares and ask questions by visiting meetnow.global/MYVD4MU as described below.

Key Points: 
  • Shareholders will not be able to attend the 2022 Annual Meeting in person; however, shareholders of record at the close of business on December 6, 2021 will be able to attend and participate in the virtual 2022 Annual Meeting, vote their shares and ask questions by visiting meetnow.global/MYVD4MU as described below.
  • Registration at the Virtual 2022 Annual Meeting: Street holders may register online at the virtual 2022 Annual Meeting by using the control number found on their voting instruction form.
  • Rules of conduct for the virtual 2022 Annual Meeting will be posted on the 2022 Annual Meeting website at meetnow.global/MYVD4MU .
  • Whether or not you plan to virtually attend BD's 2022 Annual Meeting, BD urges shareholders to vote and submit their proxy in advance by one of the methods described in the proxy materials for the 2022 Annual Meeting.